Following Rare Blood Clotting Cases, Johnson & Johnson COVID-19 Vaccine Temporarily Paused
On Tuesday, the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) recommended a temporary pause in the administration of the Johnson & Johnson COVID-19 vaccine out of an abundance of caution following the emergence of six reported cases of a rare and severe type of blood clot….
Read More »